Prognostic impact of TP53 and PPP2R1A mutations in endometrial cancer
Analysis of RWD reveals survival outcomes for co-mutated endometrial cancer
INDICATION
Endometrial
BIOMARKER
TP53
Analysis of RWD reveals survival outcomes for co-mutated endometrial cancer